Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as preparation method, quality control method and application thereof

A composition and drug technology, applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, antiviral agents, etc., can solve problems such as the curative effect needs to be improved

Active Publication Date: 2012-08-22
GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its efficacy still needs to be improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as preparation method, quality control method and application thereof
  • Medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as preparation method, quality control method and application thereof
  • Medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as preparation method, quality control method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0043] The preparation method of above-mentioned pharmaceutical composition, comprises the steps:

[0044] 1) Take the crude drug, decoct it with water, filter, and take the filtrate;

[0045] 2) centrifuging the filtrate, taking the supernatant, concentrating, and extracting the concentrate with water;

[0046] 3) adding ethanol to the concentrated water extract, stirring, standing still, and then centrifuging, taking the supernatant, removing ethanol, and obtaining the ethanol extract;

[0047] 4) Prepare the pharmaceutical preparation by combining the alcohol extract and other acceptable pharmaceutical excipients.

[0048] Furthermore, its preparation method includes the following steps:

[0049] 1) Take the raw material drug, add water to decoct 3 times, add 20 times the amount of water each time, decoct for 2 hours, let cool, filter, and combine the filtrate;

[0050] 2) Centrifuge the filtrate, take the supernatant and concentrate it to the weight of the raw material ...

Embodiment 1

[0072] Raw material composition:

[0073] 25 parts of cooked aconite, 12.5 parts of epimedium, 12.5 parts of dried ginger, 12.5 parts of licorice, 7.82 parts of red ginseng, 7.81 parts of poria cocos, 7.81 parts of knotweed, 7.81 parts of salvia miltiorrhiza, 3.75 parts of Phellodendron phellodendri, and 2.5 parts of skullcap.

Embodiment 2

[0075] Raw material composition:

[0076] 20 parts of cooked aconite, 14 parts of epimedium, 15 parts of dried ginger, 10 parts of licorice, 10 parts of red ginseng, 12 parts of poria cocos, 6 parts of knotweed, 10 parts of salvia miltiorrhiza, 5 parts of Phellodendron phellodendri, and 3 parts of skullcap.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as a preparation method, quality control method and application of the medicinal composition. The raw materials of the medicinal composition comprise cooked monkshood, herba epimedii, dried ginger, liquorice, ginseng, the root of red-rooted salvia, giant knot weed, Poria cocos, golden cypress and Scutellaria baicalensis. Experimental data indicate that the medicinal composition preparation disclosed by the invention has Aids treating function on Aids model monkeys derived from rhesus monkeys infected by monkey Aids Virus, based on the curative effect on the Aids monkey models adaptive to Aids animal models, the medicinal composition preparation has the application of treating human Aids; after being given to HIV infected persons or Aids patients, the medicinal composition preparation can relieve disease, i stabilize or improvethe CD4+T lymphocyte count level of the HIV infected persons or the Aids patients, relieve clinical clinical symptoms and improve survival quality.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating AIDS. The invention also relates to a quality control method and use of the composition. Background technique [0002] AIDS is an acquired immunodeficiency syndrome caused by HIV infection. The clinical manifestations of different stages of HIV infection process and pathogenesis are complex and diverse, including fatal malignant tumors and various opportunistic infections that occur later. [0003] People generally enter the onset period after 7-12 years after being infected with HIV-1. According to the current standard of diagnosis and treatment, antiviral therapy is not recommended for HIV carriers who are asymptomatic and whose CD+ T cell count has not been greatly reduced (for example, still above 300 per microliter), otherwise it will cause patients and society Take the huge risk of inducing severe drug resistance. According to the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P31/18
CPCA61K9/4858A61K36/076A61K36/258A61K36/296A61K36/484A61K36/537A61K36/539A61K36/704A61K36/714A61K36/756A61K36/9068A61P31/18A61K2300/00
Inventor 胡英杰符林春
Owner GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com